These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2345762)

  • 21. Acute and long-term amphetamine treatments alter extracellular ascorbate in neostriatum but not nucleus accumbens of freely moving rats.
    Yount SE; Kraft ME; Pierce RC; Langley PE; Rebec GV
    Life Sci; 1991; 49(17):1237-44. PubMed ID: 1943438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after d-amphetamine.
    Zetterström T; Sharp T; Marsden CA; Ungerstedt U
    J Neurochem; 1983 Dec; 41(6):1769-73. PubMed ID: 6196446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic and intra-accumbens administration of amphetamine differentially affects cortical acetylcholine release.
    Arnold HM; Nelson CL; Neigh GN; Sarter M; Bruno JP
    Neuroscience; 2000; 96(4):675-85. PubMed ID: 10727786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lever pressing for food reward and in vivo voltammetry: evidence for increases in extracellular homovanillic acid, the dopamine metabolite, and uric acid in the rat caudate nucleus.
    Joseph MH; Hodges H; Gray JA
    Neuroscience; 1989; 32(1):195-201. PubMed ID: 2586749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
    Compton DR; Johnson KM
    J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissociations between the effects of intra-accumbens administration of amphetamine and exposure to a novel environment on accumbens dopamine and cortical acetylcholine release.
    Neigh GN; Arnold HM; Sarter M; Bruno JP
    Brain Res; 2001 Mar; 894(2):354-8. PubMed ID: 11251215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute administration of amphetamine: differential regulation of dopamine synthesis in dopamine projection fields.
    Tyler CB; Galloway MP
    J Pharmacol Exp Ther; 1992 May; 261(2):567-73. PubMed ID: 1578374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cortical cholinergic deficiency enhances amphetamine-induced dopamine release in the accumbens but not striatum.
    Mattsson A; Olson L; Svensson TH; Schilström B
    Exp Neurol; 2007 Nov; 208(1):73-9. PubMed ID: 17714706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of ceruletide on amphetamine-induced behaviors and regional dopamine release in the rat.
    Kihara T; Ikeda M; Matsubara K; Matsushita A
    Eur J Pharmacol; 1993 Jan; 230(3):271-7. PubMed ID: 8440305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of intraventricular phenylethylamine and octopamine on the central effects of tremorine and pilocarpine and the acetylcholine level in the rat brain.
    Jagiełło-Wójtowicz E; Kleinrok A; Turski W
    Pol J Pharmacol Pharm; 1981 Oct; 33(3):265-72. PubMed ID: 6798557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat.
    Yamamoto BK; Spanos LJ
    Eur J Pharmacol; 1988 Mar; 148(2):195-203. PubMed ID: 2897922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crus cerebri lesions abolish amphetamine-induced ascorbate release in the rat neostriatum.
    Wilson RL; Kamata K; Bigelow JC; Rebec GV; Wightman RM
    Brain Res; 1986 Apr; 370(2):393-6. PubMed ID: 3518863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine-, NMDA- and sigma-receptor antagonists exert differential effects on basal and amphetamine-induced changes in neostriatal ascorbate and DOPAC in awake, behaving rats.
    Pierce RC; Rebec GV
    Brain Res; 1992 May; 579(1):59-66. PubMed ID: 1352478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The simultaneous measurement of uric acid and ascorbic acid in the lateral ventricles of freely moving rats by brain microdialysis and electrochemical detection.
    Shirachi DY; Omaye ST
    Proc West Pharmacol Soc; 1992; 35():161-3. PubMed ID: 1502216
    [No Abstract]   [Full Text] [Related]  

  • 35. D1 and D2 dopamine receptor mediation of amphetamine-induced acetylcholine release in nucleus accumbens.
    Keys AS; Mark GP
    Neuroscience; 1998 Sep; 86(2):521-31. PubMed ID: 9881866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced dopamine receptor activation in accumbens and frontal cortex has opposite effects on medial forebrain bundle self-stimulation.
    Olds ME
    Neuroscience; 1990; 35(2):313-25. PubMed ID: 2199840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ischemia/reperfusion alters uric acid and ascorbic acid levels in liver.
    Layton ME; Wood JG; Yan ZY; Forster J
    J Surg Res; 1996 Jul; 64(1):1-5. PubMed ID: 8806465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of direct and indirect dopamine agonists on brain extracellular ascorbate levels in the striatum and nucleus accumbens of awake rats.
    Phebus LA; Roush ME; Clemens JA
    Life Sci; 1990; 47(15):1317-23. PubMed ID: 1978214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of amphetamine on carrier-mediated and electrically stimulated dopamine release in slices of rat caudate putamen and nucleus accumbens.
    Iravani MM; Kruk ZL
    J Neurochem; 1995 Mar; 64(3):1161-8. PubMed ID: 7861147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biogenic amines and ascorbic acid in rat brain following steroid contraceptive treatment.
    Dey CD; Das PC; Das K; Patra PB; Dasgupta S
    Exp Clin Endocrinol; 1991 Mar; 97(1):103-6. PubMed ID: 1864309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.